Symrise stock reflects a 4.5 percent Q2 growth rebound

Published on 10/05/2026 at 17:24 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Symrise stock was trading at EUR 90.88 on Xetra on October 5, 2026, while H1 sales reached EUR 2.539 billion. Adjusted EBITDA margin was 21.8 percent, with 2026 guidance reaffirmed.

Architekturvisualisierung eines Forschungscampus mit Produktionsanlage, Symrise AG DE000SYM9999 — Symrise AG (DE000SYM9999) Architektur-Render präsentiert modernen Glas-Campus mit angrenzender industrieller Produktionsanlage und Wasserbecken im Vordergrund, Illustration mit AI erstellt.

Symrise stock (ISIN DE000SYM9999) was trading at EUR 90.88 on Xetra on October 5, 2026, down 0.13 percent during the session. The key operating signal remains the acceleration in second-quarter organic growth to 4.5 percent, which supports the company's reaffirmed 2026 outlook.

Q2 growth strengthens

Symrise reported H1 2026 sales of EUR 2.539 billion and organic growth of 2 percent, according to the Yahoo Finance transcript dated July 30, 2026. The second-quarter figure was stronger than the first-quarter trend, with sales of EUR 1.22 billion and organic growth of 4.5 percent.

The regional mix explains why the improvement matters. Organic sales rose 9.6 percent in North America and 12.3 percent in Asia Pacific during the second quarter, while EAME declined 0.4 percent and Latin America fell 2.1 percent, according to Yahoo Finance.

Margins face cost pressure

Adjusted EBITDA reached EUR 553 million in H1 2026, equal to a 21.8 percent margin, while adjusted business free cash flow increased 47 percent year over year to EUR 347 million, as reported in the Yahoo Finance transcript.

Management reaffirmed 2026 organic sales growth of 2 percent to 4 percent, an adjusted EBITDA margin of 21.5 percent to 22.5 percent, and an adjusted business free cash flow margin above 14 percent. The contrast is important: cash conversion improved sharply, but Scent and Care adjusted EBITDA declined 6.7 percent to EUR 178 million in the first half.

Consensus targets EUR 100.367

The analyst consensus on Investing.com was Buy from 16 analysts, with 11 Buy ratings, 5 Hold ratings and 0 Sell ratings. The average 12-month price target was EUR 100.367, with a high of EUR 112 and a low of EUR 75. Against the EUR 90.88 Xetra price, the average target lies 10.4 percent above the price.

Barclays raised its target from EUR 94 to EUR 96 while retaining an Equal Weight rating on September 24, 2026, according to Yahoo Finance. That view leaves the next company update as the immediate checkpoint for whether the second-quarter acceleration can continue.

October date sets next checkpoint

Symrise lists its Q3 2026 interim statement for October 28, 2026, on the investor-relations calendar. The company is a global supplier of fragrances, flavorings, cosmetic ingredients and functional solutions serving food, beverage, fragrance, personal care and pet-food customers.

Stock remains below yearly high

Symrise stock was trading at EUR 90.88 on Xetra on October 5, 2026, with a 52-week range of EUR 64.70 to EUR 95.00. Its market capitalization was EUR 12.5 billion and volume was 71,172 shares at the same timestamp.